Disease · MONDO_0005566
Comparisons in its trials17
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 17 of 17
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| A Methadone vs B Buprenorphine: Number of Children Requiring Treatment for Neonatal Abstinence Signs (NAS) | 41 of 73 | 27 of 58 | 131 | NCT00271219 | Trial comparisons |
| Clonidine vs Morphine: deaths from any cause | 1 of 60 | 0 of 60 | 120 | NCT03396588 | Trial comparisons |
| Clonidine vs Morphine: serious adverse events | 9 of 60 | 15 of 60 | 120 | NCT03396588 | Trial comparisons |
| Methadone vs Neonatal Morphine Solution: Number of Infants Needing a Second NAS Medication | 10 of 58 | 17 of 58 | 116 | NCT01958476 | Trial comparisons |
| Methadone vs Neonatal Morphine Solution: Number of Infants Needing a Dose Increase | 22 of 58 | 28 of 58 | 116 | NCT01958476 | Trial comparisons |
| Methadone vs Neonatal Morphine Solution: deaths from any cause | 0 of 58 | 0 of 58 | 116 | NCT01958476 | Trial comparisons |
| Methadone vs Neonatal Morphine Solution: serious adverse events | 5 of 58 | 3 of 58 | 116 | NCT01958476 | Trial comparisons |
| NMS/Clonidine vs NMS/Phenobarbital: serious adverse events | 0 of 34 | 0 of 34 | 68 | NCT01175668 | Trial comparisons |
| Standard Therapy ALONE vs Standard Therapy Plus Aromatherapy: deaths from any cause | 0 of 19 | 0 of 19 | 38 | NCT03097484 | Trial comparisons |
| Standard Therapy ALONE vs Standard Therapy Plus Aromatherapy: serious adverse events | 0 of 19 | 0 of 19 | 38 | NCT03097484 | Trial comparisons |
| Phenobarbital vs Clonidine: Readmission Rate | 0 of 11 | 0 of 14 | 25 | NCT03670160 | Trial comparisons |
| Phenobarbital vs Clonidine: Number of Patients Requiring Triple Therapy | 4 of 11 | 10 of 14 | 25 | NCT03670160 | Trial comparisons |
| Phenobarbital vs Clonidine: deaths from any cause | 0 of 11 | 0 of 14 | 25 | NCT03670160 | Trial comparisons |
| Phenobarbital vs Clonidine: serious adverse events | 0 of 11 | 0 of 14 | 25 | NCT03670160 | Trial comparisons |
| Treatment vs Control: deaths from any cause | 0 of 6 | 0 of 6 | 12 | NCT01360450 | Trial comparisons |
| Treatment vs Control: serious adverse events | 0 of 6 | 0 of 6 | 12 | NCT01360450 | Trial comparisons |
| Methadone Treatment Group vs Comparison Group: Readmission to Hospital | 0 of 4 | 0 of 5 | 9 | NCT03134703 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0005566/comparisons